Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an RAF1 Fusion

被引：27
|
作者：
Kim, Kevin B. [1 ]
Semrad, Thomas [2 ]
Schrock, Alexa B. [3 ]
Ali, Siraj M. [3 ]
Ross, Jeffrey S. [3 ,4 ]
Singer, Mark [1 ]
Kashani-Sabet, Mohammed [1 ]
机构：
[1] Calif Pacific Med Ctr, Res Inst, 2333 Buchanan St, San Francisco, CA 94115 USA
[2] Gene Upshaw Mem Tahoe Forest Canc Ctr, Truckee, CA USA
[3] Fdn Med, Cambridge, MA USA
[4] Albany Med Coll, Albany, NY 12208 USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
关键词：
BRAF; DABRAFENIB; TRAMETINIB; IPILIMUMAB; NIVOLUMAB; MUTATIONS; LANDSCAPE; SURVIVAL; CANCER;
D O I：
10.1200/PO.17.00138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [1] Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing
    Nakama, Kenta
    Ogata, Dai
    Nakano, Eiji
    Tsutsui, Keita
    Jinnai, Shunichi
    Namikawa, Kenjiro
    Takahashi, Akira
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2021, 48 (06): : E256 - E257
  • [2] Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene
    Boileau, Marie
    Descarpentries, Clotilde
    Delzenne, Guillaume
    Trentesaux, Victorine
    Greliak, Anna
    Jamme, Philippe
    Marchetti, Philippe
    Mortier, Laurent
    MELANOMA RESEARCH, 2023, 33 (03) : 247 - 251
  • [3] A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy
    Pacaud, Alize
    Amintas, Samuel
    Boussemart, Lise
    Cappellen, David
    Gerard, Emilie
    EUROPEAN JOURNAL OF CANCER, 2021, 147 : 161 - 163
  • [4] Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
    McEvoy, Christopher R.
    Xu, Huiling
    Smith, Kortnye
    Etemadmoghadam, Dariush
    Leong, Huei San
    Choong, David Y.
    Byrne, David J.
    Iravani, Amir
    Beck, Sophie
    Mileshkin, Linda
    Tothill, Richard W.
    Bowtell, David D.
    Bates, Bindi M.
    Nastevski, Violeta
    Browning, Judy
    Bell, Anthony H.
    Khoo, Chloe
    Desai, Jayesh
    Fellowes, Andrew P.
    Fox, Stephen B.
    Prall, Owen W. J.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (05): : 1940 - 1945
  • [5] Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma
    Khaddour, Karam
    Haq, Rizwan
    Buchbinder, Elizabeth, I
    Liu, David
    Manos, Michael P.
    Ott, Patrick A.
    Hodi, F. Stephen
    Insco, Megan L.
    ONCOLOGIST, 2024,
  • [6] MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With Pancreatic Acinar Cell Carcinoma
    McEvoy, Christopher R.
    Kee, Damien
    Prall, Owen W. J.
    Clay, Timothy D.
    Scott, Clare
    Backhouse, Anastasia
    Fox, Stephen B.
    Fellowes, Andrew P.
    Xu, Huiling
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 2
  • [7] SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy
    Chew, Sonya Minmin
    Lucas, Mairi
    Brady, Michelle
    Kelly, Catherine Margaret
    BMJ CASE REPORTS, 2021, 14 (06)
  • [8] Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma
    Hui, Caressa
    Wu, Yufan
    Liu, Kevin
    Sandhu, Navjot
    Blomain, Erik
    Binkley, Michael
    Gephart, Melanie
    Chang, Steven
    Li, Gordon
    Reddy, Sunil
    Gibbs, Iris
    Soltys, Scott
    Pollom, Erqi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S48 - S49
  • [9] Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion
    Menzies, Alexander M.
    Yeh, Iwei
    Botton, Thomas
    Bastian, Boris C.
    Scolyer, Richard A.
    Long, Georgina V.
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (05) : 607 - 610
  • [10] Successful intermittent B-Raf Inhibitor Therapy of a Patient with metastatic Melanoma - The Key to a Delay of Therapy Resistance?
    Mattern, A.
    Satzger, I
    Kapp, A.
    Alter, M.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 954 - 954
12345